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Abstract: In S. cerevisiae neither disruption of the phospholipase B triple knockout mutant (plb1plb2plb3; plb123) nor 
over-expression of phospholipase Bs (PLBs) result in a phenotype different from wild type. In performing experiments to 
characterize candidate plant phospholipase (PLA) genes, we found, surprisingly, that ectopic expression of either of two 
different A. thaliana PLA2 or PLA1 genes in the yeast plb123 mutant completely inhibited cell growth. We proposed  
that while PLBs might not be essential for growth and metabolism of yeast cells, they may play an important role in  
cell survival by metabolizing excess intracellular lysophospholipids. To test our hypothesis, we overexpressed a plant 
phospholipase A2 (PLA2) in both WT and plb123 cells, producing a pool of lysophosphatidylcholine (lysoPtdCho) in  
both transformants. In 
14C acetate labeling experiments, WT cells were able to catabolize the resultant labeled lysoPtdCho, 
preventing accumulation, and the cells grew normally. In contrast, in the triple plb123 mutant PLA2 transformant,   
lysoPtDCho accumulated more than 4-fold to a toxic level, inhibiting cell growth. However, this growth inhibition was 
complemented by co-expression of either PLB1, PLB2 or PLB3 in the plb123 triple mutant already expressing the plant 
PLA2. Furthermore, in labeling experiments, the rescued cells exhibited a 60-75% reduction in 
14C-lysoPtdCho build-up 
compared to plb123PLA2 cells. Our data  provides conclusive evidence that yeast PLBs can metabolize intracellular   
lysoPtdCho produced by plant PLA2 overexpression in yeast. Our experiments indicate the utility of ectopic plant   
phospholipase A gene expression to characterize poorly-understood phospholipid metabolism mutants in yeast or other  
organisms.  
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INTRODUCTION 
  Phospholipids are primary components of all cell mem-
branes. The main glycerolphospholipids in S. cerevisiae cells 
include, from most to least abundant, phosphatidylcholine 
(PtdCho), phosphatidylethanolamine (PtdEtn), phosphatidy-
linositol (PtdIns), phosphatidylserine (PtdSer) and phos-
phatidic acid (PtdOH). Membrane homeostasis is a dynamic 
condition wherein lipid synthesis, trafficking and degrada-
tion are coordinated to provide and sustain the integrity   
of different membranous subcellular structures [1]. In S.  
cerevisiae, lipid biosynthesis, its regulation and degradation 
are quite well understood, but much less is known about the 
biological function of lipid turnover, as well as the molecular 
mechanisms that coordinate those processes leading to 
membrane equilibrium.  
  As phospholipid turnover products, lysophospholipids 
(LysoPLs) have key roles in cell homeostasis. Due to their 
amphipathic nature, LysoPLs have surfactant and detergent-
like properties. As a result, control of the in vivo levels of 
LysoPLs is essential for the function and survival of cells. In 
yeast biological membranes, LysoPLs are typically found at  
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very low concentrations, approximately 0.02 to 0.08% of dry 
cell biomass, as derived from data of Blagovic et al. [2] and 
Summers et al. [3], respectively. The total lipid content of 
yeast varies widely with the species. The majority of yeasts 
contain 7%-15% total lipids as a proportion of dry weight 
[4]. Accordingly, the proportion of LysoPLs would fall   
into a range from 0.1%-1.1% of total lipids in different   
species. At low non-toxic concentrations, lysophospholipids 
which are metabolites of the mitogenically-responsive   
enzyme phospholipase A2, may be a mechanism for modulat-
ing the activity of downstream effector molecules. Lyso- 
phospholipids also interact with Ras proteins, regulatory 
elements for adenylyl cyclase, which catalyze the synthesis 
of cAMP, a secondary messenger critical for cell cycle   
progression [5]. However, higher concentrations of LysoPLs 
have been shown to disturb membrane conformation, affect-
ing the activities of many membrane-bound enzymes,   
and may even lead to cell lysis and death [6]. As reported by 
Ko et al. [7], yeast (1,3)--glucan synthase was shown to be 
inhibited by phospholipase A2 and its reaction products, 
principally lysophospholipids; the inhibition was due, in part, 
to non-specific detergent-like membrane disruption. This 
may partially explain the resultant inhibition of cell multipli-
cation. In wild type yeast cells, a typical phospholipid profile 
analysis does not show any appreciable lyso-phospholipid 
content [8]. In general, elevated LysoPL levels are usually A thal PLPase Expression in Yeast Shows Phospholipase Bs scavenge Toxic LPC  The Open Microbiology Journal, 2009, Volume 3    137 
characteristic of altered membrane phospholipid metabolism 
and impaired membrane integrity in particular. 
  In yeast, the de-acylation of PtDCho to produce glycero-
phosphodiester and FFA is currently known to be catalyzed 
by the enzymes Phospholipase B1, B2, B3 (Plb1p, Plb2p, 
Plb3p) and neuropathy target esterase (Nte1p), encoded by 
PLB1, PLB2, PLB3 and Nte1p genes, respectively. The PLB 
genes are highly similar (>60% identity at the DNA level). 
Phospholipase B activity catalyzes the deacylation of glyc-
erophospholipids at both sn-1 and sn-2 positions. Plbps are 
located at the plasma membrane and in the periplasmic space 
with different properties [9]. Plb1p is the main enzyme   
responsible for PtdCho deacylation with its product, glyc-
erophosphocholine (GroPCho), released into the extracellu-
lar medium. At their pH optima, substrate preferences of 
Plb1p and Plb2p are similar; both appear to accept all major 
phospholipid classes,  whereas Plb3p accepts only PtdIns   
and PtdSer as substrates. At the physiological pH of yeast 
growth medium (around pH 5), Plb1p is primarily respon- 
sible for the degradation of PtdCho, and to some extent, 
PtdIns. Interestingly, overexpression of Plb2p does not result 
in degradation of PtdCho or PtdIns, while Plb3p hydrolyses 
PtdIns, but not PtdCho, in agreement with the substrate   
selectivity observed in vitro [9, 10]. Nte1p is a phospho- 
lipase B which resides in the endoplasmic reticulum,   
and prefers to deacylate PtdCho produced through the   
CDP-choline (Kennedy) pathway [11]. PtdCho can also   
be hydrolyzed by phospholipase D (Spo14p) to produce 
phosphatidic acid (PA) [12].  
 Both  the  triple  PLB knockout mutant (plb123) and nte1 
null mutant (nte1) strains are viable and do not exhibit any 
detectable phenotype beyond the lack of GroPCho formation 
[10]. It was reported that while the plb2 mutant and plb1plb2 
double mutant grew at slightly reduced rates compared with 
wild type cells when plated on complete YEPD media [9, 
10], the plb3 mutant and plb1plb3 double mutant and the 
plb1plb2plb3 triple mutant grew the same as wild type   
on fermentable and non-fermentable carbon sources [9, 10]. 
Merkel  et al. [9] suggested that this may be due to the   
presence of alternative pathways, as was indicated by some 
residual release of GroPIns and GroPCho from a strain   
lacking all three phospholipase Bs. In fact, the plb123   
mutant grows even better than wild-type cells [9; the current 
study), prompting questions about the possible physiological 
role of Plbps. 
 S.  cerevisiae has proven to be a valuable experimental 
system to express and identify the function of plant genes 
involved in lipid metabolism. Because the plb123 triple   
mutant cells have a low background phospholipid deacyla-
tion activity, we initially tried to use the mutant as a system 
for screening and expressing some candidate plant phos- 
pholipase A ( PLA) genes. Surprisingly, we found that   
overexpressing some of the putative PLA genes in plb123 
completely inhibited the triple mutant cell growth, which 
suggested an important physiological role for PLBs. It   
had been reported that overexpression of PLB2 conferred 
resistance to the toxic effects of exogenous lysophos- 
phatidylcholine (lysoPtdCho) supplied in the medium at a 
concentration of 10 mM (ca 0.5% w/v based on the MW of 
sn-1 palmitoyl LPC), which was thought to be consistent 
with its function as an extracellular lysophospholipase [8, 9]. 
Considering this result, the fact that Plbsp are located in 
plasma membranes, and because of the existence of other 
PtdCho-hydrolysing pathways (like that involving Nte1p), 
we proposed that Plbps, while perhaps not essential for   
metabolism and growth of yeast, may also play an important 
role in cell survival by catabolizing excess intracellular   
lysophospholipids. In order to test our hypothesis, we   
decided to reverse conventional approaches and instead of 
using yeast as a vehicle to characterize plant genes, use a 
known plant phospholipase A2 (PLA2), to collect relevant 
metabolic information on the poorly-understood yeast 
plb123 mutant. Theoretically, overexpressing plant PLA2  
in yeast cells will produce a pool of lysophospholipids. If  
the cells posses the capacity to catabolize these lysophos-
pholipids, preventing accumulation, the cells will grow nor-
mally. In contrast, if the cells are devoid of this capacity, 
lysophospholipids will accumulate to a toxic concentration. 
This test system provided direct proof that Plbps, as opposed 
to other pathways, can scavenge intracellular lysoPtdCho 
produced by overexpression of PLA2. Moreover, it indicated 
the utility of using plant PLA genes to screen yeast   
phospholipid mutants and understand nature of the lesions 
therein. 
MATERIALS AND METHODOLOGY 
General Molecular Biology Materials, Media, Radio-
chemicals and Lipid Analysis Supplies 
  Yeast extract, peptone, and agar were purchased from 
Difco® Laboratories, Detroit, MI. D-(+)-Glucose and D-(+)-
galactose were acquired from Sigma-Aldrich Chemical Co., 
St. Louis, MO. Yeast nitrogen base without amino acids was 
a product of Becton, Dickinson and Company Spark, MD. 
Brent supplement mix (BSM) -URA was purchased from 
Sunrise Science, while BSM -LEU-URA was purchased 
from Formedium Ltd. Hunstanton, England. Escherichia coli 
strains Top10 and Topo10F’ competent cells, superscript   
II reverse transcriptase, DNA polymerase, pYES2.1 yeast 
shuttle vector, pCR
®2.1-Topo
® TA vector, S.c. EasyComp
Tm 
Transformation kit, restriction enzymes were purchased   
from Invitrogen, Inc., Carlsbads, CA. Pfu Turbo
®  DNA  
polymerase, pESC-Leu yeast vector were obtained from 
Stratagene. RNeasy
® plant Mini Kit, QIA prep
® Spin   
Miniprep Kit, QIA EX
® II Gel Extraction Kit were products 
of Qiagen Inc., Mississauga, ON. L--1-palmitoyl-2-oleoyl 
[1-
14C]-PtdCho was obtained from American Radiolabeled 
Chemicals, Inc, St, Louis. [1-
14C]acetate (sodium salt) was 
purchased from Amersham Biosciences. Silica Gel 60 thin 
layer chromatography plates were obtained from Whatman 
Ltd., Maidstone, England. Oligonucleotide primers were 
synthesized by the Plant Biotechnology Institute. Organic 
solvents (HPLC grade or higher) were from Fisher Scientific 
or EMD Chemicals Inc., Damstadt, Gemany. 
Yeast Strains, Growth Conditions and Transformation 
  All yeast strains used in this study (Table 1) were deriva-
tives of the plb123 (plb1plb2plb3) triple mutant and its wild 
type, W3031A, kindly provided by Dr. Olaf Merkel. Syn-
thetic minimal medium (SC) supplemented with appropriate 
nutrients (BSM-URA or BSM-LEU-URA plus glucose or 
galactose) were employed to select colonies containing vari-
ous different plasmids. Yeast transformation was performed 138    The Open Microbiology Journal, 2009, Volume 3  Zhang et al. 
using the S.c. EasyComp
Tm Transformation kit. Genomic 
yeast DNA was isolated and prepared for gene cloning   
by the method of Sambrook and Russell [13]. Escherichia 
coli strains Top10 and Top10F’ were cultured in Luria broth 
and used for plasmid transformation by a standard method 
[14].  
Cloning the PLA2 from Arabidopsis and Expression in 
Yeast 
  Total RNA was extracted from Arabidopsis leaves using 
the RNeasy
® plant Mini Kit and cDNA was synthesized by 
superscript II
® reverse transcription according to the product 
instructions. The primers PLA2F87 and PLA2R536 (see 
Table  2) were designed to amply the coding region of   
phospholipase A2 (At2g06925) [14], designated as PLA2. 
Arabidopsis leaf cDNA was used to amplify PLA2 by Pfu 
Turbo
® DNA polymerase. To the resultant blunt end PCR 
product, an adenine overhang was added at the 3' end using 
Taq DNA polymerase, and the amplicon cloned into the 
yeast shuttle vector pYES2.1 in the Top 10F’ strain. After 
confirming cloning integrity by sequencing, the vector was 
transformed into both the WT and the plb123 triple mutant 
yeast strains using the S.c. EasyComp
Tm Transformation   
kit. The self-ligated pYES2.1 was also transformed into the 
triple mutant and WT strains as controls (see Table 1).  
Table 2.  Primers Used in This Study. NotI or SacI Sites are 
Underlined  
Primer Name   Primer Sequence 
PLA2F87 ACTATGGCGGCTCCGATCA 
PLA2R536 TTAGGGTTTCTTGAGGACTTTGC 
ACTF ATGGATTCTGAGGTTGCTGCTT 
ACTR AATGGCGTGAGGTAGAGAGAAAC 
PLB1F1 GCGGCCGCATGAAGTTGCAGAGTTTGTTGG 
PLB1R1995  GAGCTCCTAAATTAGACCGAAGACGGC 
PLB2F1 GCGGCCGCATGCAATTACGGAACATATTACAG 
PLB2R2121  GAGCTCCTAAATTAGTCCAAATAATGCTGTTAT 
PLB3F1 GCGGCCGCATGATACGTCCATTATGTTCAAAA 
PLB3R2061  GAGCTCTTATACTGCTCCGGTAAACATCA  
RT-PCR Confirmation of PLA2 Expression in WT Yeast 
 Both  wild-type  S. cerevisiae bearing the empty vector 
and yeast cells bearing PLA2 were inoculated in YPD   
Table 1.  S.cerevisiae Strains Used in This Study 
Strains  Relevant Genotype  Genotype  Source 
W3031A  PLB1PLB2PLB3  Mata ade2–1 can1–100 his3–11,15 leu2–3,112 trp1–1 ura3–1  Olaf Merkel 
MF17  plb1plb2plb3  Mata ade2–1 can1–100 his3–11,15 leu2–3,112 ura3–1  
plb1::TRP plb2::HIS plb3::kanMX 
Olaf Merkel 
WTEV
a  PLB1PLB2PLB3  
YESpEV 
Mata ade2–1 can1–100 his3–11,15 leu2–3,112 trp1–1  
ura3–1 YESpEV 
This study 
WTPLA2  PLB1PLB2PLB3  
PLA2 
Mata ade2–1 can1–100 his3–11,15 leu2–3,112 trp1–1  
ura3–1 YESpPLA2 
This study 
plbEV  plb1plb2plb3  
YESpEV 
Mata ade2–1 can1–100 his3–11,15 leu2–3,112 ura3–1  
plb1::TRP plb2::HIS plb3::kanMX YESpEV 
This study 
plbPLA2  plb1plb2plb3  
PLA2 
Mata ade2–1 can1–100 his3–11,15 leu2–3,112 ura3–1  
plb1::TRP plb2::HIS plb3::kanMX  
YESpPLA2 
This study 
plbEVEV  plb1plb2plb3  Mata ade2–1 can1–100 his3–11,15 leu2–3,112 ura3–1  
plb1::TRP plb2::HIS plb3::kanMX  
YESpEV ESCpEV 
This study 
plbPLA2  
EV 
plb1plb2plb3  
PLA2 
Mata ade2–1 can1–100 his3–11,15 leu2–3,112 ura3–1  
plb1::TRP plb2::HIS plb3::kanMX  
YESpPLA2 ESCpEV 
This study 
plbPLA2  
PLB1 
plb1plb2plb3  
PLA2PLB1 
Mata ade2–1 can1–100 his3–11,15 leu2–3,112 ura3–1  
plb1::TRP plb2::HIS plb3::kanMX  
YESpPLA2 ESCpPLB1 
This study 
plbPLA2  
PLB2 
plb1plb2plb3  
PLA2PLB2 
Mata ade2–1 can1–100 his3–11,15 leu2–3,112 ura3–1  
plb1::TRP plb2::HIS plb3::kanMX  
YESpPLA2 ESCpPLB2 
This study 
plbPLA2  
PLB3 
plb1plb2plb3  
PLA2PLB3 
Mata ade2–1 can1–100 his3–11,15 leu2–3,112 ura3–1  
plb1::TRP plb2::HIS plb3::kanMX  
YESpPLA2 ESCpPLB3 
This study 
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medium containing 2% of dextrose. Cells were cultured at 
28°C for 24 hr, followed by culture in YPD medium contain-
ing 2% -galactose at 28°C for 12 hr. Total RNA was   
isolated from
 both wild-type S. cerevisiae bearing the empty 
vector and transgenic cells bearing PLA2 using the standard 
method of Sambrook and Russell [13]. To examine the trans- 
cript levels in transformed yeast, two micrograms of DNase 
I-treated RNA were
 used as a template for cDNA synthesis 
(Invitrogen superscript
  First-Strand Synthesis kit). To   
exclude genomic DNA contamination, DNA-free RNAs 
were tested by PCR using pLA2 primers (See Table 2). The 
yeast actin gene ACT1/YFL039C  was amplified (using 
primers ACTF and ACTR, Table 2) and used as an endo- 
genous standard to confirm mRNA quality. The cDNA   
samples were diluted 50-fold for PCR
  amplification.
  The 
PCR program: DNA denaturation at 94°C for 4 min,   
followed by 35 cycles of PCR at 94°C for 30 seconds; 
primer annealing
 at 53°C for 30 seconds and extension and 
incubation at 72°C for 5.75 min, then cooling at 4°C. PCR 
products were resolved by electrophoresis on 1% agarose 
gels. The expected amplified
 fragment size of yeast actin and 
pLA2 are 525 bp and 450 bp, respectively. Functional   
expression of the PLA2 was confirmed by phospholipase   
A2 assay as described below. 
Plate Assay of Strain Growth 
  All strains were cultured to stationary phase in SC   
medium with glucose and adjusted to an OD600 of 3.0 as a 
starting concentration; cells were also diluted 1:10, 1:100 
and 1:1000 with SC medium without saccharide. Ten μl of 
each was spotted on plates with different media containing 
either glucose or galactose. After 2, 3 and 5 days, the degree 
of cell growth was determined.  
Phospholipase A2 Assay 
  PLA2 activity was measured as the release of radioactive 
free [1-
14C] oleic acid from the substrate L--1-palmitoyl-2-
oleoyl[1-
14C]-PtdCho. The substrate was dried under a 
stream of N2 before adding the other reaction components. 
Standard enzyme assay mixtures contained 50 mM Tris-HCl, 
pH 8.0, 10 mM CaCl2, 0.05% (v/v) Triton X-100, 0.1μCi of 
the substrate (55mCi/mmol), in a total volume of 200 μl. The 
mixtures were emulsified by sonication at room temperature 
for 3 min. and reactions started by addition of 60 μg of trans-
formant lysate protein. The reactions were incubated in a 
shaking water bath at 30ºC for 30 min and terminated by the 
addition of 750 μL of chloroform: methanol (1:2, v/v). The 
lipids were extracted and spotted onto a thin layer chromato- 
graphy plate (Silica Gel G), which was developed with   
chloroform: methanol: NH4OH: water (73:30:4:1). The spots 
corresponding to the lipid standards FFA and lysoPtdCho, 
were then scraped into vials, 4 ml scintillation fluid added 
(Aquasol-2, DuPont) and the radioactivity determined by 
standard scintillation counting. 
Labeling Yeast Cells with Radioactive Sodium Acetate 
and Lyso-Phosphocholine Analysis 
  Yeast cells were cultured in SC-URA medium with   
glucose. The cells from stationary stage cultures were diluted 
to OD600 0.1 in a 20 ml volume. 30Ci of [1-
14C]- labeled 
sodium acetate was diluted in SC medium and the labeled 
solution filtered before adding to the cultures. The cells were 
inoculated and incubated for 10 hours at 28ºC. The cultures 
were then divided in half; One half continued to be incubated 
in glucose medium, while with the other half, collected cells 
were washed twice with sterilized water and transferred   
to galactose medium. After 5 hours incubation, cells were 
collected and washed twice with PBS (10 mM phosphate, 
2.7 mM KCl, 137 mM NaCl, pH7.4), to be analyzed for   
lipids. Cells were homogenized with an equal volume of 
glass beads using the BeadBeater at 4ºC using 3 bursts of 1 
min. Total lipids were extracted by adding 2 ml of chloro-
form:methanol:KCl/HNO3(1:2:0.8,v/v/v) vortexing and then 
adding 2ml dichloromethane and the total lipids were 
recovered from the lower organic phase. The labeled lipids 
were separated by two-dimensional thin layer chromato- 
graphy on Silica gel 60 plates using chloroform/methanol/ 
acetic acid/water (80:9:12:2) as the first, and chloro-
form/methanol/acetic acid/water (50:25:10:2) as the second 
developing solvent, respectively. The TLC plates were 
screened by a TLC Imaging Scanner (Bioscan, WA, USA). 
Relevant spots were scraped and quantified by liquid scintil-
lation counting.  
Co-Culture Experiments 
  The plb123 mutant was transformed by two empty   
vectors with URA and LEU selection markers respectively 
(designated plbEVEV). while the wild type cells were trans-
formed by PLA2 expression vector or its empty vector 
pYES2.1 with URA selection marker only and designated   
as WTPLA2 and WTEV, respectively. The WTPLA2 was 
then co-cultured with plbEVEV (WTEV co-cultured with 
plbEVEV was used as the control). Under the induced condi-
tion, we wanted to determine whether WTPLA2 could   
release enough lysoPC to affect the growth of plb123 mutant 
cells. In order to fully reflect the PLA2 effect, 10-times the 
number of WTPLA2 cells and WTEV cells were grown 
against plbEVEV cells, which were mixed together for   
co-culture as follows: After WTEV, WTPLA2 and plbEVEV 
were cultured to OD600 3.0, WTEV and WTPLA2 cells were 
each diluted to OD600 1.0 while plbEVEV cells were diluted 
to OD600  0.1 and then the preparations co-cultured. Then 
either before induction or after two days induction in the 
presence of galactose, cultures were diluted 100-fold and 10 
l was spread on plates with SC-URA-LEU medium and 
colonies counted.  
Cloning the PLB1, PLB2 and PLB3 Genes from Yeast 
and Expression in the plb123 triple Mutant 
  Yeast DNA was extracted by the method of Sambrook 
and Russell [13]. The primers PLB1F1, PLB1R1995, 
PLB2F1, PLB2R2121, PLB3F1, PLB3R2061 (see Table 2) 
with NotI or SacI sites (underlined) were designed to amply 
the coding region of PLB1, PLB2, and PLB3, respectively 
using Pfu Turbo
® DNA polymerase. To the resultant blunt 
end PCR products, adenine overhangs were added at the 3' 
ends using Taq DNA polymerase and the amplicons cloned 
into pCR
®2.1-Topo
® TA vector. After confirming sequence 
integrity, the plasmids were digested by NotI/SacI, the 
1.99kb PLB1, 2.12kb PLB2 and 2.06kb PLB3 were recov-
ered from the gel and each ligated into the NotI/SacI sites in 
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pYES2.1PLA2 (described above) were co-transformed into 
the plb123 triple mutant using the S.c. EasyComp
Tm Trans-
formation kit and transformant cells selected on SC-LEU-
URA medium. The self-ligated pYES2.1 and empty pESC-
Leu vector were also used to transform the triple mutant 
strain as a control. The product strains and their genotypes 
are shown in Table 1.  
RESULTS 
  While screening a number of putative plant PLA genes by 
over-expression in the plb123 triple mutant strain, we found 
that there was generally a complete inhibition of growth. 
Thus, we considered using a reverse strategy- one of using  
a known plant PLA2 gene to determine whether PLBs may 
play an important role in cell survival, perhaps by scaveng-
ing excess lysophospholipids. Although there are reports that 
PLA activity can be measured in yeast, there have been no 
yeast PLA genes cloned thus far [15], making the availability 
of the plant PLA gene even more valuable in probing yeast 
phospholipid metabolism mutations. A PLA2 gene from 
Arabidopsis (At2g06925) encodes a 149-amino acid protein, 
identified as phospholipase A2, which deacylates phosphol-
ipids at the sn-2 position to produce lysophospholipids  
and FFAs [14]. The Arabidopsis PLA2 was cloned into the 
yeast shuttle vector pYES2.1, in which PLA2 was driven   
by GAL1 promoter (see Materials and methods). The GAL1 
promoter can be inhibited by glucose and stimulated by   
galactose [16].  
Functional Expression of the Arabidopsis PLA2 in Yeast 
  WT yeast strain W3031A was transformed with either 
pYESPLA2 plasmid or with empty vector (control). PLA2 
expression was confirmed by RT-PCR (Fig. 1). To assess 
whether the expressed AtPLA2  had functional activity,   
cells were collected from exponential stage cultures induced  
in galactose medium, lysed and the lysate used in phos- 
pholipase A2 assays as described in Materials and methodol-
ogy. The release of sn-2 
14C-labeled oleic acid from L--1-
palmitoyl-2-oleoyl[1-
14C]-PtdCho was 15-fold higher than 
the low background activity in the WT yeast. This experi-
ment confirmed that the plant PLA2 gene was functionally 
expressed in yeast cells and encoded a protein with   
phospholipase A2 activity. Furthermore, expression of the 
AtPLA2 was not toxic to WT yeast. 
The Over-Expression of Plant PLA2s Completely   
Inhibits the Growth of Yeast plb123 Triple Mutant   
Cells but has no Obvious Effect on Wild Type Cells 
  When the Arabidopsis PLA2 was introduced into the 
plb123 triple mutant and maintained on SC-URA medium 
with glucose, the PLA2 was not expressed, and there were no 
obvious changes in cell growth compared to the empty vec-
tor controls or the WTPLA2 transformants. Once cultured in 
the medium containing galactose, the empty vector control 
cells and WTPLA2 cells grew normally, but the growth of 
plb123 cells harbouring PLA2 (plbPLA2) was completely 
inhibited (Fig. 2). The results were identical even after 5 
days of incubation (data not shown). These results show that 
the growth inhibition of the plb123 triple mutant was due to 
the expression of PLA2, and that such inhibition acts only in 
the plb123 triple mutant cells, but not in wild type cells.  
  To determine whether the cells were dead or growth 
merely inhibited when PLA2 was expressed, cells induced 
for 3 and 6 days in galactose liquid medium were collected 
and washed, re-suspended in glucose medium and re-plated 
on glucose plates. The cells were once again able to grow, 
suggesting that overexpression of AtPLA2 was not lethal to 
the plb123 cells, but rather, temporarily inhibited cell growth 
(data not shown). 
 
 
 
 
 
 
 
 
Fig. (1). Expression of Arabidopsis PLA2 in WT yeast as determined by RT-PCR. Lane 1. Template: WTEV cDNA, Actin primers; Lane 2. 
Template: WTPLA2 cDNA, Actin primers; Lane 3. Template: WTEV cDNA, PLA2 primers; Lane 4. Template: WTPLA2 cDNA,   
PLA2 primers; Lane 5. Template: DNA-free RNA from WTEV, PLA2 primers; Lane 6. Template: DNA-free RNA from WTPLA2, PLA2 
primers. Lanes 1 & 2 show that the cDNA from both empty vector- and PLA2- transformed yeast were of good quality, as the yeast actin was 
constitutively expressed in both samples. Lane 3: The same empty vector-transformed WT yeast as in Lane 1, failed to produce the PLA2 
transcript; Lane 4: In contrast, PLA2-transformed WT yeast produced the expected 450 bp PLA2 transcript. For Lanes 5 & 6, using DNA-
free RNA as the template there is no signal with the PLA2 primers, confirming that there is no possibility that genomic DNA contamination 
in the cDNA templates could have resulted in the PLA2 band as observed in Lane 4. A thal PLPase Expression in Yeast Shows Phospholipase Bs scavenge Toxic LPC  The Open Microbiology Journal, 2009, Volume 3    141 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Cell growth of Wild type empty vector (WTEV), wild type 
PLA2 (WTPLA2), plb123 empty vector (plbEV) and plb123 PLA2 
(plbPLA2) transformants (as designated in Table 1) on medium 
supplemented with glucose or galactose. All strains were cultured 
to stationary phase in SC medium with glucose and adjusted to 
OD600 of 3.0 as a starting cell density; Cells were also diluted 10, 
100 and 1000 times and 10 μl of each was spotted on a plate with 
medium as indicated and incubated for three days. 
The Over-Expression of Plant PLA2s Leads to A Toxic 
Accumulation of lysoPtdCho in plb123 Cells 
  Once we confirmed that the plant PLA2 was functionally 
expressed (see above), we speculated that its overexpression 
could be used to stimulate an accumulation of lysophos- 
pholipids and/or free fatty acids, which might be toxic to   
the plb123 cells. No obvious accumulation of free fatty   
acids was found in growth-inhibited cells (data not shown). 
Because of the very low level of endogenous lysophos- 
pholipids, such as lysoPtdCho, in yeast cells, it was neces-
sary to label the phospholipids by feeding cells with 
14C  
acetate to estimate relative polar lipid pool sizes. In prelimi-
nary experiments, we found that the phospholipids were 
well-labeled during the exponential phase but not in later 
phases (data not shown). This is consistent with the fact that 
neutral, not polar, lipids accumulate in the late phase of cell 
growth. Thus labeling was performed during the exponential 
phase of growth.  
  While most major phospholipids of WTEV, WTPLA2, 
plbEV and plbPLA2 strains were all labeled, among lyso 
phospholipids only lysoPtdCho (and not lysoPtdEtn,  lyso 
PtdIns, lysoPtdSer) was significantly labeled. The level of 
lysoPtdCho in induced plbPLA2 increased more than 4-fold 
over the low endogenous level consistently observed in   
control cells (Fig. 3). In WT cells expressing PLA2 (WTPLA2) 
there was no enhanced accumulation of lysoPtdCho and cell 
growth was unaffected. Collectively, these results mean that 
the over-expression of plant PLA2 can be used to produce 
lysophospholipids, mainly lysoPtdCho, which can be cata- 
bolized by wild type yeast, but accumulates in the plb triple 
mutant. This suggests that phospholipase Bs play an impor-
tant role in scavenging excessive lysoPtdCho in yeast cells 
and that the plb123 mutant has lost this ability.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Relative 
14C labeling of various phospholipids isolated from transformed strains fed with 
14C acetate. Starting from a cell density of 
0.1 (OD600) in 20 ml of glucose medium, cells of WTEV, WTPLA2, plbEV and plbPLA2 (as designated in Table 1) were labeled with 30 
Ci 
14C-sodium acetate for 10 hours. Half of culture remained in glucose medium while the other half was induced in galactose medium  
for 5 hours. The total lipids were extracted and resolved by two dimensional thin layer chromatography and each of the phospholipids was 
quantified (see Materials and methodology). The proportions of 
14C-labeled LysoPtdCho (relative to the total 
14C phospholipids) are depicted 
using the Y axis scale on the right side, while the proportions of other 
14C-labeled phospholipids are expressed using the Y axis scale on the 
left. The results are the means ±S.E of three experiments. 142    The Open Microbiology Journal, 2009, Volume 3  Zhang et al. 
The Growth Inhibition of the plb123 Mutant Upon   
AtPLA2 Expression is Principally the Result of Intra- 
cellular Accumulation of lysoPC 
 Because  in  Arabidopsis, PLA2, has been observed in 
both intracellular and extracellular spaces [14] , the possibil-
ity remained that the expressed AtPLA2 is producing lysoPC 
extracellularly at a level high enough to also inhibit the 
growth of the plb123 mutant. In that case, using PLA2  
expression to produce lysoPC would not be a qualitatively 
different experiment than providing lysoPC to the culture 
media. To demonstrate that it was the ectopic expression of 
the plant PLA2 giving rise to increased intracellular lysoPC 
that was primarily responsible for the growth inhibition, we 
designed the following co-culture experiment: The plb123 
mutant was transformed by two empty vectors with URA 
and LEU selection markers, respectively (designated 
plbEVEV), while the wild type cells were transformed with 
the PLA2 expression vector or with its empty vector 
pYES2.1, with URA selection marker only, and designated 
as WTPLA2 and WTEV, respectively. We then co-cultured 
WTPLA2 with plbEVEV and, as a control, we co-cultured 
WTEV with plbEVEV. Under induced (+ gal) conditions, we 
wondered whether WTPLA2 might release some amount of 
extracellular lysoPC, which might affect the growth of the 
plb123 mutant cells. After two days of induction, the co-
cultures were diluted and spread on plates with SC-URA-
LEU medium. Due to the presence of the both selection nu-
trients, only plbEVEV cells were able to grow, while WTEV 
or WTPLA2 could not. By counting colony numbers it was 
possible to evaluate the effect of lysophospholipids released 
by WTPLA2 on plbEVEV cells. Our results showed that 
there is no difference in growth between the two co-cultures 
(Table  3). Combining these results with those from 
14C  
acetate labeling experiments (above), it is clear that the   
intracellular accumulation of lysoPC by AtPLA2 expression 
was the principle reason for the growth inhibition of the 
plb123 mutant.  
The Expression of PLB1, or PLB2 or PLB3 can   
Eliminate the Inhibition of PLA2s on plb123 Triple   
Mutant Cell Growth 
  In order to determine whether one or other of the   
phospholipase Bs could rescue plb123 cell growth which had 
been inhibited by the over-expression of AtPLA2, each PLB 
gene was co-expressed separately with PLA2 in plb123. All 
three PLB genes could rescue cell growth (Fig. 4). Under our 
experimental conditions, there was no difference in the rate 
of growth in the rescued cells. Most importantly, 
14C acetate 
labeling experiments showed that those cells rescued by co-
expression of any of the three PLB genes exhibited a 60-75% 
reduction in the 
14C  lysoPtdCho which otherwise accumu-
lated to a toxic level in the case of the plb123PLA2 trans-
formant (Fig. 5). Thus, it appears that lysoPtdCho threshold 
proportions of 0.5% or higher are highly toxic to the plb123 
mutant, which is supported by the earlier findings of Merkel 
et al. [9] and Fyrst et al. [8] in studies of PLPB2 as a puta-
tive extra-cellular lysophospholipase. We also co-expressed 
in plb123,  one of PLB1,  PLB2 or PLB3 with another   
Arabidopsis PLA gene, PLA1 (At2g44810), and found that 
the growth inhibition caused by this PLA1 could also be   
rescued by each of the PLBs (data not shown). These results 
demonstrate that PLBs are redundant in scavenging excess 
lysoPtdCho, and that such mechanisms are generally induced 
by plant PLA expression in plb123 cells.  
DISCUSSION 
 LysoPtdCho is an important lysophospholid in cells; its 
potential generation and degradation in yeast cells is summa-
rized in the simplified model shown Fig. (6). The production 
of lysoPtdCho occurs via different pathways: One is via the 
deacylation of PtdCho by Plb1p, Plb2p and Nte1p [8, 9, 11, 
17]; In the other pathway, lysoPtdCho is taken up into the 
intracellular compartment by the action of Dnf2p [18, 19]. 
When GroPcho is taken up into yeast by Git1p, lysoPtdCho 
can be produced by GPCAT [20, 21]. LysoPtdCho can be 
Table 3.  The Growth Inhibition of the plb123 Mutant Upon AtPLA2 Expression is Principally the Result of Intracellular Accumu-
lation of lysoPC. In Co-Cultivation Experiments, the plb123 Mutant was Transformed by Empty Vectors pYES2.1 and 
pESC with URA and LEU Selection Markers (Called plbEVEV), WT was Transformed by the Empty Vector (Called 
WTEV) or by PLA2 (Called WTPLA2) with the URA Selection Marker. The WTPLA2 was Then Co-Cultured with 
plbEVEV (WTEV Co-Cultured with plbEVEV was Used as the Control). Cells were Induced to Determine Whether 
WTPLA2 Could Release Enough lysoPC to Affect the Growth of plb123 Mutant Cells. In Order to Fully Reflect the PLA2 
Effect, 10-Times the Number of WTPLA2 Cells and WTEV Cells were Grown Against plbEVEV Cells, which were Mixed 
Together for Co-Culture as Follows: After WTEV, WTPLA2 and plbEVEV were Cultured to OD600 3.0, WTEV and 
WTPLA2 Cells were Each Diluted to OD600 1.0 while plbEVEV Cells were Diluted to OD600 0.1 and Then the Preparations 
Co-Cultured. Then Either Before Induction or After Two Days Induction in the Presence of Galactose, Cultures were  
Diluted 100-fold and 10 l was Spread on Plates with SC-URA-LEU Medium and Colonies Counted.   
Co-Culture Strain Combination  Induction Time  # of Cells / mL Culture 
WTEV + plbEVEV  0 hr  2.77E+05 ± 1.533E+04 
WTPLA2 + plbEVEV  0 hr  2.83E+05 ± 5.774E+03 
WTEV + plbEVEV  48 hr  1.40E+06 ± 1.447E+05 
WTPLA2 + plbEVEV  48 hr  1.42E+06 ± 1.422E+05 
Values are reported as # of colonies per mL of culture and are the average of three replicates ± SD. A thal PLPase Expression in Yeast Shows Phospholipase Bs scavenge Toxic LPC  The Open Microbiology Journal, 2009, Volume 3    143 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). Co-expression of either PLB1 or PLB2 or PLB3 with PLA2, respectively, in the plb123 triple mutant. All strains are designated by 
those plasmids expressed in the plb strain as designated in Table 1 (e.g. plbPLA2PLB1 for the plb triple mutant co-expressing the Arabidopsis 
PLA2 and the yeast PLB1). Transformants were cultured to the stationary phase in SC medium with glucose and adjusted to an OD600 of 3.0 
and also diluted by 10, 100 and 1000-fold; 10 μl of each was spotted on plates with different media. The photograph was taken after 3 days of 
growth. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (5). Relative 
14C lysoPtdCho content in 
14C acetate labeling experiments conducted following co-expression of either PLB1 or PLB2 or 
PLB3 with PLA2, respectively, in the plb123 triple mutant. All strains are designated by those plasmids expressed in the plb strain as ex-
plained for Table 3 and indicated in Table 1. Starting from a cell density of 0.1 (OD600) in 20 ml of glucose medium, cells of plbPLA2EV, 
plbPLA2PLB1, plbPLA2PLB2 and plbPLA2PLB2 were labeled with 30 Ci 
14C-sodium acetate for 10 hours, then induced in galactose  
medium for 5 hours. The total lipids were extracted and resolved by two dimensional thin layer chromatography and the 
14C lysoPtdCho was 
quantified (see Materials and methods). The plb123 triple mutant expressing only the PLA2, designated as plbPLA2EV, accumulated 
14C 
lysoPtdCho to 1.0 % of the total phospholipid (PL) fraction, as was typical in previous experiments (See Fig. 3). The plbPLA2PLB1, 
plbPLA2PLB2 and plbPLA2PLB3 co-transformants exhibited 60-75% reductions in the relative 
14C lysoPtdCho content. Values are the  
average of 2 replicates. 144    The Open Microbiology Journal, 2009, Volume 3  Zhang et al. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (6). Simplified scheme of lysoPtdCho metabolism in Saccharomyces cerevisiae. Abbreviations are: LysoPtDCho (lysophosphatidylcho-
line), GroPCho (glycerophosphocholine), PtDCho (phosphatidylcholine), LPCAT (lysophosphylcholine:acyl-CoA acyltransferase), mtTaz1 
(mitochondrial acyl-CoA-independent LPCAT; [25]; Plb1p, Plb2p, Plb3p (phopholipases B1, B2 and B3), Nte1p (neuropathy target esterase);  
Dnf1p and Dnf2p (aminophospholipid translocating P-type ATPases 1 and 2, respectively); Lem3p (noncatalytic  subunit of Dnf1p   
and Dnf2p); GPCAT (glycerophosphocholine acyltransferase); LRO1 (phospholipid:diacylglycerol acyltransferase; PDAT; [19, 26]; Git1P 
(glycerophosphoinositol/glycerophosphocholine transporter; [27]. Not shown in schematic: PLBs are also involved in the hydrolysis of PC 
and PI to produce extracellular glycerophosphocholine and glycerophophoinositol, respectively [28].  
produced in vitro in yeast lysates via Lro1, transferring an 
acyl group from PC to diacylglycerol [22].  
  There are several ways to eliminate excess lysoPtdCho. 
LysoPtdCho can be converted to PtdCho in the presence of 
acyl-CoA by lysophosphylcholine:acyl-CoA acyltransferase 
(LPCAT; EC 2.3.1.23) and there are several recent reports  
to support this [23-27]. Over-expression of LPCAT can   
enhance the cell’s resistance to lysoPtdCho [27]. In yeast, 
there is also a mitochondrial acyl-CoA-independent LPCAT 
activity, mediated by Taz1 [28]. Finally, lysoPtdCho can   
also be catabolized via Plb1p, Plb2p, Plb3p or Nte1p. Over-
expression of PLBs was known to enhance cell resistance to 
lysoPtdCho and the plb123 triple mutant cells showed more 
sensitivity to LysoPtdCho [8, 9] . At the time, extracellular 
PLB activity was known but the existence of the exogenous 
lysolipid metabolism (ELM) pathway, reported only recently 
[19], was not. Thus it was thought that PLBs could degrade 
exogenous lysophospholipids and increase the resistance to 
the occurrence of such lipids in the medium; the degradation 
of LysoPtdCho by PLBs was considered to occur only extra-
cellularly. 
  In our hands, and consistent with these previous studies, 
when cultured on synthetic minimal medium (SC) supple-
mented with appropriate nutrients (BSM-URA or BSM-
LEU-URA plus glucose or galactose), we did not observe 
any apparent difference in growth rate between the wild type 
and plb1plb2plb3 triple mutant. In this study, by means of 
expressing an AtPLA2 in plb123 and WT cells and compar-
ing their growth with un-induced cells, we found that expres-
sion of AtPLA2 could completely inhibit growth of the 
plb123 triple mutant cells, but not that of wild type cells. 
Further investigation revealed that excessive lysoPtdCho 
accumulation occurred only in plb123 cells expressing the 
AtPLA2. Co-cultivation experiments supported the hypothe-
sis that this effect was due primarily to intracellular, rather 
than extracellular, lysoPtdCho accumulation.  
  Complementation experiments showed that all three 
PLBs could rescue the growth inhibition of plb123 triple 
mutant cells caused by AtPLA2 expression. Finally, in addi-
tion to relief from growth inhibition, the cells of 
plb123PLA2 complemented with PLBs also exhibited a 
dramatic 60-75% reduction in lysoPtdCho accumulation. 
Collectively, these findings directly support our hypothesis 
that Plbps play a very important role in catabolizing excess 
intracellular  lysoPtdCho. Phospholipase B exhibits three 
activities in vitro: 1) phospholipase A activity; 2) lysophos-
pholipase activity; 3) transacylase activity. The lysophos-
pholipase activity of Plb1p and Plb2p is about 100 fold 
higher than its PLPase A activity; even its transacylase activ-
ity is higher than that of PLPase A. In this regard, it is 
probably more suitable to refer to Plbs as lysophospholipases 
or transacylases, rather than phospholipase Bs. As the excep-
tion, no lysophospholipase activity has been detected in 
Plb3p, but it shows some transacylase activity [12]. Thus, 
our observation that Plb3p can rescue the growth inhibition 
of the plb123 triple mutant expressing the AtPLA2, might be 
due to Plb3p acting as a transacylase.  
CONCLUSION 
  In conclusion, our results show that PLBs can efficiently 
eliminate excess lysoPtdCho produced by PLA2 to maintain 
healthy cell growth. In the absence of any experimental evi-
dence, it cannot be excluded that extrusion and processing by 
transporters such as Nte1p, also contribute to the processing 
of lysoPC to maintain homeostasis. It is, however, interesting 
to note that, even though NTE1 and LPCAT are still present 
in the plb123 mutant, our results suggest that the intracellular 
lysoPtdCho which accumulates in the presence of over- 
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expressed Arabidopsis PLAs is more reliant on PLBs to 
maintain yeast membrane homoestasis through lipid catabo-
lism. Our results do not preclude other roles for PLBs. Given 
that the common reaction product of PLAs acting on PtdCho 
is  lysoPtdCho, and that we were able only to observe   
increases in this specific lyso-phospholipid upon expression 
of PLA2, it is reasonable to assume that the over-expression 
product in this case is solely lysoPtdCho. However, this does 
not  a priori, rule out other unknown lipid products being 
produced.  
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